The influence of the COVID-19 pandemic on the prescription of multiple sclerosis medication in Germany

The findings reveal that while MS prescriptions spiked during lockdowns, overall medication use in Germany stayed remarkably stable throughout the pandemic. This study offers compelling insights into the resilience of healthcare systems during unprecedented challenges.

By Orschiedt, J., Jacyshyn-Owen, E., Kahn, M., Jansen, S., Joschko, N., Eberl, M., … Ziemssen, T. (2023). The influence of the COVID-19 pandemic on the prescription of multiple sclerosis medication in Germany. Biomedicine & Pharmacotherapy, 158(114129), 114129.